Knight Therapeutics (TSE:GUD)
TSX:GUD
Holding TSE:GUD?
Track your performance easily

Knight Therapeutics (GUD) Ownership - Who Owns Knight Therapeutics?

89 Followers

Knight Therapeutics (GUD) Ownership Overview

34.60%1.99%0.09%0.78%62.54%
34.60% Insiders
0.09% Other Institutional Investors
0.78% ETFs
62.54% Public Companies and
Individual Investors
The ownership structure of Knight Therapeutics (TSE:GUD) stock is a mix of institutional, retail, and individual investors. Approximately 2.86% of the company’s stock is owned by Institutional Investors, 34.60% is owned by Insiders, and 62.54% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 12, 2024
Samira Sakhia
President & Chief Executive Officer
xxxxxxxxxxxxx
C$103000
Sep 23, 2024
Sime Armoyan
Shareholder, >10% Owner
xxxxxxxxxxxxx
C$1839000
Aug 20, 2024
Amal Khouri
Chief Business Officer
xxxxxxxxxxxxx
C$54507
Jun 14, 2024
Robert Nathaniel Lande
Non Executive,director
xxxxxxxxxxxxx
C$118710

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
21,764,635Insider21.55%80,746,796
12,366,200Insider12.25%45,878,602
1,256,903Institution1.24%4,663,110
411,025Institution0.41%1,524,903
348,983Institution0.35%1,294,727
309,781Institution0.31%1,149,288
286,651Institution0.28%1,063,475
268,178Insider0.27%994,940
258,278Insider0.26%958,211
157,161Insider0.16%583,067

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,256,903Institution1.24%4,663,110
411,025Institution0.41%1,524,903
286,651Institution0.28%1,063,475
26,600Institution0.03%98,686
19,818Institution0.02%73,525
5,400Institution<0.01%20,034
3,700Institution<0.01%13,727
2,400Institution<0.01%8,904

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
178,832Institution0.18%676,853
108,965Institution0.11%411,913
70,949Institution0.07%268,532
65,016Institution0.06%246,076
62,333Institution0.06%235,921
40,685Institution0.04%214,003
18,505Institution0.02%104,923
22,855Institution0.02%86,503
9,653Institution<0.01%50,775
6,832Institution<0.01%31,427

FAQ

Who Owns Knight Therapeutics (TSE:GUD)?
According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 34.60% is held by insiders, and 62.54% is held by retail investors.
    What percentage of Knight Therapeutics (TSE:GUD) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.09% of Knight Therapeutics (TSE:GUD) stock is held by institutional investors.
      What percentage of Knight Therapeutics (TSE:GUD) stock is held by retail investors?
      According to the latest TipRanks data, approximately 62.54% of Knight Therapeutics (TSE:GUD) stock is held by retail investors.
        Who owns the most shares of Knight Therapeutics (TSE:GUD)?
        Jonathan Ross Goodman owns the most shares of Knight Therapeutics (TSE:GUD).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis